MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway.

Cao, Shengya; Li, Longfei; Li, Jia; Zhao, Hongying.

Afiliación

Cao S; Department of Clinical Laboratory, Xuzhou Cancer Hospital, Xuzhou, Jiangsu, People's Republic of China.
Li L; Department of Thoracic Surgery, Xuzhou Cancer Hospital, Xuzhou, Jiangsu, People's Republic of China.
Li J; Department of Central Laboratory, Xuzhou Cancer Hospital, Xuzhou, Jiangsu, People's Republic of China.
Zhao H; Department of Oncology, Xuzhou Cancer Hospital, Xuzhou, Jiangsu, People's Republic of China.

Onco Targets Ther ; 13: 7493-7502, 2020.

Article en En | MEDLINE | ID: mdl-32801771